Literature DB >> 33932221

Rezum: a novel minimally invasive treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. A review article.

Ahmed Higazy1, Dana Osman2, Tarek Osman3.   

Abstract

Lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) are one of the most common morbidities in elderly men, especially in aging societies. Minimally invasive surgical treatments (MISTs) for BPH have gained an increasing interest in the current time. Rezum system is a novel MIST that uses water vapour-based convective thermal therapy to ablate prostatic tissue. According to our evaluation of the existing literature, Rezum offers a meaningful relief of LUTS with a high safety profile without compromising the sexual activity especially to those who are unfit for surgery or to those who do not desire to continue on lifelong pharmacotherapy.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Ablation therapy; Benign prostatic hyperplasia; Convective energy source; Lower urinary tract symptoms; Minimally invasive treatment; Rezum; Thermal energy; Water vapour therapy

Mesh:

Substances:

Year:  2021        PMID: 33932221     DOI: 10.1007/s11255-021-02878-8

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  15 in total

Review 1.  Emerging Minimally Invasive Treatment Options for Male Lower Urinary Tract Symptoms.

Authors:  Giuseppe Magistro; Christopher R Chapple; Mostafa Elhilali; Peter Gilling; Kevin T McVary; Claus G Roehrborn; Christian G Stief; Henry H Woo; Christian Gratzke
Journal:  Eur Urol       Date:  2017-07-19       Impact factor: 20.096

2.  Rezūm Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: 4-Year Results From Randomized Controlled Study.

Authors:  Kevin T McVary; Tyson Rogers; Claus G Roehrborn
Journal:  Urology       Date:  2019-01-21       Impact factor: 2.649

3.  Rezum water vapour therapy: promising early outcomes from the first UK series.

Authors:  Maximilian J Johnston; Mohamed Noureldin; Yehia Abdelmotagly; Louise Paramore; Tina Gehring; Timothy G Nedas; Govindaraj Rajkumar; Amr Emara; Richard G Hindley
Journal:  BJU Int       Date:  2020-08-30       Impact factor: 5.588

4.  The Rezūm system - a minimally invasive water vapor thermal therapy for obstructive benign prostatic hyperplasia.

Authors:  Christopher H Cantrill; Kevin C Zorn; Dean S Elterman; Ricardo R Gonzalez
Journal:  Can J Urol       Date:  2019-06       Impact factor: 1.344

5.  Three-Year Treatment Outcomes of Water Vapor Thermal Therapy Compared to Doxazosin, Finasteride and Combination Drug Therapy in Men with Benign Prostatic Hyperplasia: Cohort Data from the MTOPS Trial.

Authors:  Nikhil Gupta; Tyson Rogers; Bradley Holland; Sevann Helo; Danuta Dynda; Kevin T McVary
Journal:  J Urol       Date:  2018-03-01       Impact factor: 7.450

Review 6.  Can we identify men who will have complications from benign prostatic obstruction (BPO)? ICI-RS 2011.

Authors:  Matthias Oelke; Ruth Kirschner-Hermanns; Nikesh Thiruchelvam; John Heesakkers
Journal:  Neurourol Urodyn       Date:  2012-03-13       Impact factor: 2.696

7.  Convective Thermal Therapy: Durable 2-Year Results of Randomized Controlled and Prospective Crossover Studies for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.

Authors:  Claus G Roehrborn; Steven N Gange; Marc C Gittelman; Kenneth A Goldberg; Kalpesh Patel; Neal D Shore; Richard M Levin; Michael Rousseau; J Randolf Beahrs; Jed Kaminetsky; Barrett E Cowan; Christopher H Cantrill; Lance A Mynderse; James C Ulchaker; Thayne R Larson; Christopher M Dixon; Kevin T McVary
Journal:  J Urol       Date:  2016-12-18       Impact factor: 7.450

8.  Oncological safety and functional outcomes of testosterone replacement therapy in symptomatic adult-onset hypogonadal prostate cancer patients following robot-assisted radical prostatectomy.

Authors:  Hanna Shahine; Marc Zanaty; Ahmed S Zakaria; David-Dan Nguyen; Felix Couture; Iman Sadri; Russel Schwartz; Adel Arezki; Dean Elterman; Assaad El-Hakim; Kevin C Zorn
Journal:  World J Urol       Date:  2020-10-09       Impact factor: 4.226

9.  Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study.

Authors:  Kevin T McVary; Steven N Gange; Marc C Gittelman; Kenneth A Goldberg; Kalpesh Patel; Neal D Shore; Richard M Levin; Michael Rousseau; J Randolf Beahrs; Jed Kaminetsky; Barrett E Cowan; Christopher H Cantrill; Lance A Mynderse; James C Ulchaker; Thayne R Larson; Christopher M Dixon; Claus G Roehrborn
Journal:  J Sex Med       Date:  2016-04-27       Impact factor: 3.802

10.  An Indirect Comparison of Newer Minimally Invasive Treatments for Benign Prostatic Hyperplasia: A Network Meta-Analysis Model.

Authors:  Karthik Tanneru; Seyed Behzad Jazayeri; Muhammad Umar Alam; Jatinder Kumar; Soroush Bazargani; Gretchen Kuntz; Hariharan Palayapalayam Ganapathi; Mark Bandyk; Robert Marino; Shahriar Koochekpour; Shiva Gautam; K C Balaji; Joseph Costa
Journal:  J Endourol       Date:  2021-01-25       Impact factor: 2.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.